It also was found that PA1 inhibit topoisomerase II but not topoisomerase I. In order to assess the cytotoxic potential of PA1 and its effect on the cell cycle, two human leukemia cell lines, HL-60 and HL-60/MX2, were used. Here, PAGR1 is linked to leukemia.